tiprankstipranks
Trending News
More News >
China Apex Group Ltd. (HK:2011)
:2011
Hong Kong Market

China Apex Group Ltd. (2011) AI Stock Analysis

Compare
0 Followers

Top Page

HK

China Apex Group Ltd.

(2011)

Rating:70Outperform
Price Target:
HK$1.50
▲(9.49%Upside)
The overall score reflects strong financial performance with significant revenue and profitability improvements, balanced by moderate technical indicators and valuation. The lack of earnings call data and corporate events did not impact the score, allowing financial metrics to play a dominant role in the assessment.

China Apex Group Ltd. (2011) vs. iShares MSCI Hong Kong ETF (EWH)

China Apex Group Ltd. Business Overview & Revenue Model

Company DescriptionChina Apex Group Ltd. (2011) is a diversified company engaged in various sectors, including manufacturing, trading, and services. The company focuses on delivering high-quality products and solutions across different industries, including electronics, consumer goods, and industrial products. With a commitment to innovation and customer satisfaction, China Apex Group Ltd. has established a strong presence in both domestic and international markets.
How the Company Makes MoneyChina Apex Group Ltd. generates revenue through multiple streams, primarily from manufacturing and trading activities. The company produces a wide range of products, which are distributed through its extensive network, catering to both B2B and B2C segments. Additionally, the company engages in strategic partnerships and collaborations, enhancing its market reach and product offerings. Revenue is also supplemented by providing specialized services related to its core product lines, ensuring a comprehensive approach to customer needs.

China Apex Group Ltd. Financial Statement Overview

Summary
China Apex Group Ltd. has demonstrated strong revenue growth, improved profitability with a positive net profit margin, and solid cash flow generation. However, increased leverage on the balance sheet poses some risk, though it is mitigated by effective equity utilization and significant ROE improvement.
Income Statement
78
Positive
In the latest year, China Apex Group Ltd. showed strong revenue growth of 25.1%, indicating a positive trajectory. The gross profit margin improved to 52.7%, reflecting effective cost management. The net profit margin turned positive to 9.7% after previous losses, showcasing enhanced profitability. EBIT and EBITDA margins also improved significantly, suggesting operational efficiencies. These metrics indicate a robust recovery and a solid financial position in the TTM period.
Balance Sheet
70
Positive
The debt-to-equity ratio increased to 1.14, indicating higher leverage, which may pose risks if not managed carefully. However, the equity ratio remained healthy at 32.8%, reflecting a stable capital structure. ROE improved significantly to 17.9%, demonstrating effective use of equity to generate income. Overall, the balance sheet shows a mix of increased leverage with strong equity utilization.
Cash Flow
82
Very Positive
Free cash flow saw significant growth due to improved operating cash flow, now at 42.4 million. The operating cash flow to net income ratio of 1.31 indicates strong cash generation from operating activities. The company's ability to generate free cash flow is a positive sign of financial health and sustainability, reflecting efficient cash management practices.
Breakdown
Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income StatementTotal Revenue
333.38M266.55M215.58M239.72M170.09M
Gross Profit
175.51M110.54M69.71M71.91M34.23M
EBIT
35.57M-5.40M4.24M-11.29M-38.50M
EBITDA
83.42M-34.46M37.97M20.10M-16.74M
Net Income Common Stockholders
32.30M-69.04M658.00K-16.91M-51.21M
Balance SheetCash, Cash Equivalents and Short-Term Investments
141.48M63.90M105.27M59.87M60.93M
Total Assets
551.79M278.10M305.71M275.78M290.70M
Total Debt
206.10M72.01M43.09M50.30M64.17M
Net Debt
64.62M41.00M-62.18M-9.57M3.24M
Total Liabilities
359.19M144.64M99.30M111.01M117.66M
Stockholders Equity
180.87M123.38M184.91M141.67M151.87M
Cash FlowFree Cash Flow
42.36M-13.33M276.00K15.72M-2.02M
Operating Cash Flow
42.36M1.30M15.65M35.59M18.67M
Investing Cash Flow
37.96M-8.36M-13.65M-18.25M3.02M
Financing Cash Flow
12.33M-33.38M50.53M-20.81M-56.59M

China Apex Group Ltd. Technical Analysis

Technical Analysis Sentiment
Positive
Last Price1.37
Price Trends
50DMA
1.35
Positive
100DMA
1.32
Positive
200DMA
1.36
Positive
Market Momentum
MACD
0.01
Negative
RSI
70.27
Negative
STOCH
85.96
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:2011, the sentiment is Positive. The current price of 1.37 is above the 20-day moving average (MA) of 1.34, above the 50-day MA of 1.35, and above the 200-day MA of 1.36, indicating a bullish trend. The MACD of 0.01 indicates Negative momentum. The RSI at 70.27 is Negative, neither overbought nor oversold. The STOCH value of 85.96 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for HK:2011.

China Apex Group Ltd. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (62)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
81
Outperform
HK$260.53B15.5328.11%2.52%11.51%47.88%
80
Outperform
$1.40T40.3914.98%38.46%72.44%
78
Outperform
$39.77B12.1411.92%23.40%1.85%-6.19%
76
Outperform
$94.18B20.4913.20%2.44%-9.60%-27.18%
70
Outperform
HK$787.06M24.5121.23%25.07%
66
Neutral
HK$88.71B46.756.14%1.61%7.63%-24.23%
62
Neutral
$6.80B11.082.79%5.80%2.68%-24.86%
* Consumer Cyclical Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
HK:2011
China Apex Group Ltd.
1.38
-0.56
-28.87%
HK:1177
Sino Biopharmaceutical
4.85
2.20
83.36%
HK:1810
Xiaomi
53.05
34.53
186.45%
HK:2020
ANTA Sports Products
90.95
13.43
17.33%
HK:2331
Li Ning Company
15.00
-2.22
-12.90%
HK:1093
CSPC Pharmaceutical Group
7.61
1.42
22.94%

China Apex Group Ltd. Corporate Events

Gilston Group Limited Announces Annual General Meeting Agenda
May 22, 2025

Gilston Group Limited has announced its upcoming Annual General Meeting, scheduled for June 19, 2025, in Hong Kong. The meeting will address several key agenda items including the adoption of the company’s financial statements for 2024, re-election of directors, and the re-appointment of auditors. Additionally, shareholders will consider resolutions to authorize the board to repurchase shares and issue new shares, with specific limits set on the number of shares involved. These resolutions, if passed, could impact the company’s capital management strategies and shareholder value.

China Apex Group Ltd. Achieves Financial Turnaround in 2024
Mar 30, 2025

China Apex Group Ltd. reported a significant financial turnaround for the year ended December 31, 2024, with a 25.1% increase in revenue to HK$333,376,000 and a gross profit rise of 58.8% to HK$175,509,000. The company achieved a profit of HK$32,904,000, marking a substantial improvement from the previous year’s loss. This financial recovery is reflected in the growth of total assets by 98.4% and cash reserves by 123.4%, indicating strengthened financial stability and potential for future growth.

Gilston Group Limited Projects Significant Profit Turnaround for 2024
Mar 25, 2025

Gilston Group Limited has announced a positive profit alert, expecting a net profit between HK$20 million and HK$35 million for the year ending December 31, 2024, compared to a net loss of approximately HK$69 million in the previous year. This turnaround is attributed to a full year of revenue from its property management business and stabilized performance in its zipper business, which did not incur any impairment losses this year.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.